Related Experiment Videos
[Histamine-release and migraine]
Abstract:
Some studies suggested a role for histamine in the pathogenesis of the migraine. So we decided to investigate the histamine-release in two groups of patients: 8 common migraine patients, 8 healthy subjects. Plasma from either controls or migraineurs were mixed with the same control whole blood and histamine release was measured using a radio-enzymatic assay. Migraine plasma induced an histamine release significantly more important than control plasma (p less than 0.01). The nature of an "histamine releasing factor" in the plasma of migraine patient is discussed. This work is an argument for a possible immuno-allergic process in migraine.
Insights
Migraine patients' plasma triggers significantly more histamine release than healthy individuals, suggesting a potential immuno-allergic component in migraine pathogenesis. This finding highlights histamine's role in common migraine.
Area of Science:
- Neuroscience
- Immunology
- Allergy
Context:
- Migraine is a complex neurological disorder with debated pathogenesis.
- Histamine is a biogenic amine implicated in various physiological and pathological processes.
- Previous research suggested a potential role for histamine in migraine development.
Purpose:
- To investigate histamine release in patients with common migraine compared to healthy controls.
- To explore the presence of a histamine-releasing factor in the plasma of migraineurs.
Summary:
- This study compared histamine release in 8 common migraine patients and 8 healthy subjects.
- Plasma from migraineurs, when mixed with control whole blood, induced significantly greater histamine release (p < 0.01) compared to plasma from controls.
- A radio-enzymatic assay was used to measure histamine release.
Impact:
- The findings suggest that plasma from migraine patients contains a factor that promotes histamine release.
- This provides evidence supporting a possible immuno-allergic mechanism in the pathogenesis of common migraine.
- Further research into this histamine-releasing factor could lead to novel diagnostic or therapeutic strategies for migraine.